Atria Wealth Solutions Inc. Has $5.25 Million Stock Holdings in Colgate-Palmolive Company (NYSE:CL)

Atria Wealth Solutions Inc. grew its holdings in Colgate-Palmolive Company (NYSE:CL - Free Report) by 29.8% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 56,063 shares of the company's stock after buying an additional 12,884 shares during the quarter. Atria Wealth Solutions Inc.'s holdings in Colgate-Palmolive were worth $5,253,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CL. Cornerstone Wealth Management LLC lifted its position in shares of Colgate-Palmolive by 1.2% during the 1st quarter. Cornerstone Wealth Management LLC now owns 9,035 shares of the company's stock valued at $847,000 after acquiring an additional 110 shares during the period. Aberdeen Wealth Management LLC lifted its position in shares of Colgate-Palmolive by 0.6% during the 4th quarter. Aberdeen Wealth Management LLC now owns 20,651 shares of the company's stock worth $1,877,000 after buying an additional 125 shares during the last quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO lifted its position in shares of Colgate-Palmolive by 4.0% during the 1st quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO now owns 3,388 shares of the company's stock worth $317,000 after buying an additional 130 shares during the last quarter. Continuum Advisory LLC lifted its position in shares of Colgate-Palmolive by 17.2% during the 4th quarter. Continuum Advisory LLC now owns 893 shares of the company's stock worth $81,000 after buying an additional 131 shares during the last quarter. Finally, KFG Wealth Management LLC lifted its position in shares of Colgate-Palmolive by 1.5% during the 1st quarter. KFG Wealth Management LLC now owns 8,835 shares of the company's stock worth $828,000 after buying an additional 131 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages recently weighed in on CL. UBS Group dropped their price objective on Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating for the company in a research report on Thursday, July 17th. Morgan Stanley dropped their price objective on Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating for the company in a research report on Monday. JPMorgan Chase & Co. dropped their price objective on Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating for the company in a research report on Monday. Wells Fargo & Company dropped their target price on Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating for the company in a research report on Monday. Finally, Barclays increased their target price on Colgate-Palmolive from $86.00 to $87.00 and gave the company an "equal weight" rating in a research report on Tuesday, July 15th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $98.92.

Colgate-Palmolive Trading Up 1.8%

Shares of CL stock opened at $84.58 on Thursday. The stock has a market cap of $68.36 billion, a price-to-earnings ratio of 23.76, a PEG ratio of 4.32 and a beta of 0.35. The stock has a 50-day moving average of $89.07 and a 200-day moving average of $90.18. The company has a current ratio of 0.89, a quick ratio of 0.28 and a debt-to-equity ratio of 6.79. Colgate-Palmolive Company has a 1-year low of $82.40 and a 1-year high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.03. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%. The company had revenue of $5.11 billion during the quarter, compared to analysts' expectations of $5.03 billion. During the same quarter in the prior year, the firm posted $0.91 earnings per share. The business's quarterly revenue was up 1.0% on a year-over-year basis. On average, equities research analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 15th. Investors of record on Friday, July 18th will be paid a dividend of $0.52 per share. The ex-dividend date of this dividend is Friday, July 18th. This represents a $2.08 annualized dividend and a yield of 2.5%. Colgate-Palmolive's dividend payout ratio (DPR) is currently 58.43%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.